Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone vs Glyburide on Vascular Structure in Type 2 Diabetes
NCT00123643Phase 4Completed
- Sponsor
- St. Paul Heart Clinic
- Start
- May 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by St. Paul Heart Clinic. Started May 2003; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00123643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123643.